Significance of Clinical-Pathological Correlation in Ponatinib Reactions

Significance of Clinical-Pathological Correlation in Ponatinib Reactions

Authors

  • Judith Monserrat Corona Herrera National Institute of Medical Sciences and Nutrition Salvador Zubirán
  • Fanny Carolina López Jiménez National Institute of Medical Sciences and Nutrition Salvador Zubirán
  • Verónica Monserrat Díaz Sánchez National Institute of Medical Sciences and Nutrition Salvador Zubirán
  • Betzabé Quiles Martínez National Institute of Medical Sciences and Nutrition Salvador Zubirán
  • Marcela Saeb Lima National Institute of Medical Sciences and Nutrition Salvador Zubirán
  • Silvia Méndez Flores National Institute of Medical Sciences and Nutrition Salvador Zubirán

Keywords:

Ponatinib, Adverse Drug Reactions, Stevens-Johnson Syndrome

References

Ikeda M, Fujita T, Amoh Y, Mii S, Matsumoto K, Iwamura M. Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma. Urol Int. 2013;91(4):482-3. DOI: 10.1159/000351918. PMID: 23969404.

Massaro F, Molica M, Breccia M. Ponatinib: A Review of Efficacy and Safety. Curr Cancer Drug Targets. 2018;18(9):847-56. DOI: 10.2174/1568009617666171002142659. PMID: 28969556.

Hsiao LT, Chung HM, Lin JT, et al. Stevens-Johnson syndrome after treatment with STI571: a case report. Br J Haematol. 2002;117(3):620-22. DOI:10.1046/j.1365-2141.2002.03499.x. PMID: 12028031.

Chaigne B, Lagier L, Aubourg A, et al. Stevens-Johnson Syndrome induced by masitinib. Acta Derm Venereol. 2012;92(2):210-2. DOI: 10.2340/00015555-1196. PMID: 21953477.

Danish M, Patel V, Arava S, Ahuja R. Ponatinib-induced desquamation-Unifying eponymous terminology for a rare adverse event. J Eur Acad Dermatol Venereol. 2024;38(3):e247-e249. DOI:10.1111/jdv.19553 Danish M, Patel V, Arava S, Ahuja R. Ponatinib-induced desquamation-Unifying eponymous terminology for a rare adverse event. J Eur Acad Dermatol Venereol. 2024;38(3):e247-e249. DOI: 10.1111/jdv.19553. PMID: 37795667.

Downloads

Published

2025-01-29

How to Cite

1.
Corona Herrera JM, López Jiménez FC, Díaz Sánchez VM, Quiles Martínez B, Saeb Lima M, Méndez Flores S. Significance of Clinical-Pathological Correlation in Ponatinib Reactions. Dermatol Pract Concept. 2025;15(1):4713. doi:10.5826/dpc.1501a4713

Share